カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 1,008 | 1,034 | 1,001 | 1,005 | -6 | -0.6% | 24,000 |
| 2022/03/30 | 976 | 1,022 | 976 | 1,011 | -20 | -1.9% | 22,300 |
| 2022/03/29 | 1,044 | 1,057 | 1,030 | 1,031 | -17 | -1.6% | 19,000 |
| 2022/03/28 | 1,020 | 1,060 | 1,012 | 1,048 | +27 | +2.6% | 27,400 |
| 2022/03/25 | 1,040 | 1,041 | 1,019 | 1,021 | -19 | -1.8% | 25,400 |
| 2022/03/24 | 996 | 1,071 | 995 | 1,040 | +39 | +3.9% | 68,900 |
| 2022/03/23 | 1,001 | 1,012 | 996 | 1,001 | +1 | +0.1% | 12,200 |
| 2022/03/22 | 1,017 | 1,017 | 995 | 1,000 | -5 | -0.5% | 6,100 |
| 2022/03/18 | 995 | 1,008 | 993 | 1,005 | +14 | +1.4% | 14,000 |
| 2022/03/17 | 981 | 1,002 | 981 | 991 | +14 | +1.4% | 10,600 |
| 2022/03/16 | 990 | 990 | 977 | 977 | ±0 | ±0% | 5,700 |
| 2022/03/15 | 963 | 985 | 963 | 977 | +5 | +0.5% | 7,100 |
| 2022/03/14 | 968 | 982 | 960 | 972 | +8 | +0.8% | 7,900 |
| 2022/03/11 | 951 | 969 | 951 | 964 | -1 | -0.1% | 5,000 |
| 2022/03/10 | 946 | 968 | 946 | 965 | +28 | +3% | 8,400 |
| 2022/03/09 | 945 | 947 | 929 | 937 | -5 | -0.5% | 10,400 |
| 2022/03/08 | 945 | 969 | 931 | 942 | -33 | -3.4% | 27,600 |
| 2022/03/07 | 981 | 983 | 962 | 975 | -9 | -0.9% | 15,500 |
| 2022/03/04 | 990 | 998 | 978 | 984 | -15 | -1.5% | 15,200 |
| 2022/03/03 | 1,003 | 1,012 | 996 | 999 | -8 | -0.8% | 14,400 |
| 2022/03/02 | 1,017 | 1,020 | 995 | 1,007 | -8 | -0.8% | 14,200 |
| 2022/03/01 | 1,022 | 1,030 | 1,008 | 1,015 | -1 | -0.1% | 17,500 |
| 2022/02/28 | 1,001 | 1,016 | 980 | 1,016 | +6 | +0.6% | 40,000 |
| 2022/02/25 | 933 | 1,085 | 933 | 1,010 | +75 | +8% | 140,000 |
| 2022/02/24 | 939 | 960 | 932 | 935 | -17 | -1.8% | 20,300 |
| 2022/02/22 | 968 | 980 | 948 | 952 | -28 | -2.9% | 34,000 |
| 2022/02/21 | 980 | 980 | 963 | 980 | ±0 | ±0% | 8,700 |
| 2022/02/18 | 973 | 994 | 970 | 980 | -8 | -0.8% | 22,700 |
| 2022/02/17 | 1,001 | 1,001 | 985 | 988 | -17 | -1.7% | 25,500 |
| 2022/02/16 | 994 | 1,020 | 994 | 1,005 | +12 | +1.2% | 26,500 |
| 2022/02/15 | 1,023 | 1,025 | 990 | 993 | -31 | -3% | 49,700 |
| 2022/02/14 | 1,051 | 1,055 | 1,023 | 1,024 | -42 | -3.9% | 51,300 |
| 2022/02/10 | 1,067 | 1,078 | 1,061 | 1,066 | -1 | -0.1% | 19,900 |
| 2022/02/09 | 1,062 | 1,076 | 1,057 | 1,067 | +5 | +0.5% | 24,100 |
| 2022/02/08 | 1,081 | 1,097 | 1,052 | 1,062 | -19 | -1.8% | 43,500 |
| 2022/02/07 | 1,116 | 1,125 | 1,073 | 1,081 | -44 | -3.9% | 52,600 |
| 2022/02/04 | 1,125 | 1,137 | 1,110 | 1,125 | -23 | -2% | 61,100 |
| 2022/02/03 | 1,188 | 1,205 | 1,148 | 1,148 | -52 | -4.3% | 76,100 |
| 2022/02/02 | 1,205 | 1,216 | 1,177 | 1,200 | -16 | -1.3% | 86,600 |
| 2022/02/01 | 1,272 | 1,310 | 1,204 | 1,216 | -58 | -4.6% | 293,200 |
| 2022/01/31 | 1,384 | 1,390 | 1,188 | 1,274 | -82 | -6% | 568,800 |
| 2022/01/28 | 1,225 | 1,366 | 1,201 | 1,356 | +131 | +10.7% | 753,300 |
| 2022/01/27 | 1,155 | 1,275 | 1,126 | 1,225 | +113 | +10.2% | 485,600 |
| 2022/01/26 | 1,099 | 1,160 | 1,063 | 1,112 | +31 | +2.9% | 125,000 |
| 2022/01/25 | 1,200 | 1,244 | 1,078 | 1,081 | -97 | -8.2% | 343,900 |
| 2022/01/24 | 1,125 | 1,178 | 1,125 | 1,178 | +62 | +5.6% | 111,600 |
| 2022/01/21 | 1,143 | 1,239 | 1,090 | 1,116 | ±0 | ±0% | 279,700 |
| 2022/01/20 | 1,080 | 1,139 | 1,073 | 1,116 | +66 | +6.3% | 61,600 |
| 2022/01/19 | 1,070 | 1,085 | 1,047 | 1,050 | -31 | -2.9% | 18,900 |
| 2022/01/18 | 1,073 | 1,100 | 1,070 | 1,081 | +16 | +1.5% | 18,000 |
651～
700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 120,000円 | +6.8% | -13.8% | 2.67% | 9.20倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| クリングル | 84,500円 | +240.0% | - | 0.00% | - | 2.75倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入ｉＰＳ由来細胞医薬や抗体医薬開発に注力 |
市場注目の銘柄
チャート関連のコラム
